Biodegradable poly(sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: Preparation and in vitro characterization

J. G. Hiremath*, V. Kusum Devi, Kshama Devi, A. J. Domb

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

The aim of this study was to prepare tamoxifen citrate loaded cylindrical polymeric implants for application at tumor sites. The implant was based on poly (sebacic acid-co-ricinoleic-ester anhydride) 70 : 30 w/w [poly(SA-RA) 70 : 30 w/w], a low-melting, biodegradable, and biocompatible polymer. Implants were prepared by a standardized melt manufacturing method. Differential scanning calorimetry and scanning electron microscopy were used for implant characterization. In vitro drug release studies were performed in phosphate-buffered saline (pH 7.4) at 37 ± 2°C. The drug content was estimated by high-performance liquid chromatography. The differential scanning calorimetry studies showed that the tamoxifen citrate in the implants was in the amorphous state. The cumulative percentage of drug release from 10 and 20 wt% drug-loaded poly(SA-RA) 70:30 w/w implants after 30 days was found to be 42.36 and 62.60%, respectively.

Original languageEnglish
Pages (from-to)2745-2754
Number of pages10
JournalJournal of Applied Polymer Science
Volume107
Issue number5
DOIs
StatePublished - 5 Mar 2008

Keywords

  • Biodegradable
  • Drug delivery systems
  • Implant
  • Injection molding

Fingerprint

Dive into the research topics of 'Biodegradable poly(sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: Preparation and in vitro characterization'. Together they form a unique fingerprint.

Cite this